Act now: Contact your MEP and ask them to support and ask ECDA's questions to Commissioners designate
The position involves a strong focus on improving the estimation of burden of disease. Read more...
Read the global policy and civil society report on prevention and control of viral hepatitis
Now 4060 members from 106 countries
Conference Highlights: EASL-AASLD Special Conference Prague 2012

Email to a friend

EASL would like to thank everyone who attended for making the Prague Special Conference on Therapy of Hepatitis C: Clinical Application and Drug Development, an enormous success.

This was a landmark event, being the first Special Conference on the topic of HCV co-organised by both EASL and the AASLD; the result was outstanding attendance, and a strengthened bond between the two associations.

EASL has prepared this Conference Highlights report featuring key topics discussed and presented during the Special Conference in Prague. This report will enable you to keep up to date with the latest happenings in the field.

Share